-
., Pharm.D., or M.D. in biomedical or related sciences (Chemistry, Pharmacy, Molecular Biology, Biochemistry, Pathology, Biomedical Engineering, etc.) with at least one year of bench research experience
-
candidate will have (or be soon completing) a doctoral degree in biomedical engineering, chemical engineering, pharmaceutics, or a related field. The candidate must be highly motivated with evidence of
-
are desirable. The successful candidate will be joining a team of biomedical engineers, cancer biologists, and radiation oncologists and will contribute to the ongoing work in the treatment of cancer and other
-
will subsequently help us to develop new ligands to specifically treat patients suffering from these common diseases and to develop more precise medications in the future. We will use nanoparticle
-
cell technology. Experience with RNA sequencing, gene editing (CRISPR-Cas9), single particle imaging, and large data set analysis. Proficiency in programming languages like R, python, Matlab Online
-
data to identify novel disease phenotypes. The candidates will work within a highly multi-disciplinary team of physicians, physiologists, electrical and biomedical engineers and computer scientists and
-
cutting-edge technology, the selected candidate will aim to reveal the underlying mechanisms of T cell and innate immunity to influenza virus Education Requirement: PhD, MD/PhD or MD with significant bench